Jim Cramer Shed Light on These 8 Stocks Recently

6. Hims & Hers Health, Inc. (NYSE:HIMS)

Number of Hedge Fund Holders: 31

A caller asked Cramer his opinion on Hims & Hers Health, Inc. (NYSE:HIMS), and here’s what he said in response:

“Listen to me and listen to me good… Here’s what happens. This stock is a short squeeze and as long as people are shorting, it’s gonna go higher and the, the moment it’s not, it’s gonna go lower. That’s too hard for me to call.”

Hims & Hers (NYSE:HIMS) provides a telehealth platform offering prescription and non-prescription health and wellness products and services, including medication, skin care, sexual health, hair care, and wellness items, along with ongoing care from licensed healthcare professionals. Interestingly enough, Cramer recommended starting a position in the stock back in July 2024 as he remarked:

“I’d never recommend paying up for HIMS after that big run to $25, but now that it’s pulled back to $20, I think you can justify building a position here, especially if you buy it gradually on the way down and don’t place all your hopes on the temporary GLP-1 business, even as it is incredibly strong… I liked Hims & Hers before this whole GLP-1 dalliance sent it into the stratosphere. Those great first quarter numbers didn’t have any benefit from knock-off GLP-1s, and I bet the business stays strong.”

Since his comment, Hims & Hers (NYSE:HIMS) stock has gained over 107%.